Henry Ford Health System in Detroit will lead a 3,000-person U.S. study to determine the effectiveness of hydroxychloroquine in preventing COVID-19 infections. (April 3)

Subscribe for more Breaking News: http://smarturl.it/AssociatedPress

Website: https://apnews.com

Twitter: https://twitter.com/AP

Facebook: https://facebook.com/APNews

Google+: https://plus.google.com/115892241801867723374

Instagram: https://www.instagram.com/APNews/

You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/6bfd01a3768249fdbb9d29a79fdcff18